Search Results

There are 74128 results for: content related to: Milestones in neuroimaging

  1. Monitoring Disease Progression in Parkinson's Disease

    The Journal of Clinical Pharmacology

    Volume 41, Issue S7, July 2001, Pages: 72S–80S, Doris J. Doudet

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270001417011

  2. Functional Imaging Studies in Parkinson's Disease: The Non-Dopaminergic Systems

    Parkinson's Disease: Non-Motor and Non-Dopaminergic Features

    C. Warren Olanow, Fabrizio Stocchi, Anthony E. Lang, Pages: 105–110, 2011

    Published Online : 27 JUN 2011, DOI: 10.1002/9781444397970.ch9

  3. Biomarkers for trials of neuroprotection in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 1, January 2013, Pages: 71–85, Pankaj A. Agarwal and A. Jon Stoessl

    Article first published online : 24 AUG 2012, DOI: 10.1002/mds.25065

  4. Central pharmacokinetics of levodopa: Lessons from imaging studies

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 73–79, A. Jon Stoessl

    Article first published online : 1 OCT 2014, DOI: 10.1002/mds.26046

  5. Parkinson's disease is not a long-latency illness

    Movement Disorders

    Volume 12, Issue 6, November 1997, Pages: 849–854, Dr. P. K. Morrish

    Article first published online : 4 NOV 2004, DOI: 10.1002/mds.870120603

  6. PET IMAGING OF THE PHARMACOKINETICS OF SMALL MOLECULAR-WEIGHT DRUGS

    Drug Delivery Applications of Noninvasive Imaging: Validation from Biodistribution to Sites of Action

    Stephen M. Moerlein, Zhude Tu, Pages: 147–191, 2013

    Published Online : 20 SEP 2013, DOI: 10.1002/9781118356845.ch7

  7. Neuroimaging: Current role in detecting pre-motor Parkinson's disease

    Movement Disorders

    Volume 27, Issue 5, 15 April 2012, Pages: 634–643, Jana Godau, Anna Hussl, Praween Lolekha, A. Jon Stoessl and Klaus Seppi

    Article first published online : 16 APR 2012, DOI: 10.1002/mds.24976

  8. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

    Annals of Neurology

    Volume 47, Issue 4, April 2000, Pages: 493–503, Chong S. Lee, Ali Samii, Vesna Sossi, Thomas J. Ruth, Michael Schulzer, James E. Holden, Jess Wudel, Pramod K. Pal, Raul De La Fuente-Fernandez, Donald B. Calne and A. Jon Stoessl

    Article first published online : 26 APR 2001, DOI: 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4

  9. Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: A simulation study for [18F]FDOPA PET by a model with detailed dopamine pathway

    Synapse

    Volume 65, Issue 8, August 2011, Pages: 751–762, Keisuke Matsubara, Hiroshi Watabe, Yoshitaka Kumakura, Takuya Hayashi, Christopher J. Endres, Kotaro Minato and Hidehiro Iida

    Article first published online : 21 MAR 2011, DOI: 10.1002/syn.20899

  10. Dopamine turnover increases in asymptomatic LRRK2 mutations carriers

    Movement Disorders

    Volume 25, Issue 16, 15 December 2010, Pages: 2717–2723, Vesna Sossi, Raul de la Fuente-Fernández, Ramachandiran Nandhagopal, Michael Schulzer, Jessamyn McKenzie, Thomas J. Ruth, Jan O. Aasly, Matthew J. Farrer, Zbigniew K. Wszolek and Jon A. Stoessl

    Article first published online : 11 OCT 2010, DOI: 10.1002/mds.23356

  11. [18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies

    American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

    Volume 141B, Issue 3, 5 April 2006, Pages: 245–249, Brad A. Racette, Laura Good, Jo Ann Antenor, Lori McGee-Minnich, Stephen M. Moerlein, Tom O. Videen and Joel S. Perlmutter

    Article first published online : 9 MAR 2006, DOI: 10.1002/ajmg.b.30293

  12. Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function

    Synapse

    Volume 64, Issue 2, February 2010, Pages: 146–151, André R. Troiano, Michael Schulzer, Raul de La Fuente-Fernandez, Edwin Mak, Jess Mckenzie, Vesna Sossi, Siobhan Mccormick, Thomas J. Ruth and A. Jon Stoessl

    Article first published online : 22 OCT 2009, DOI: 10.1002/syn.20708

  13. Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 608–615, Elina Nurmi, Hanna M. Ruottinen, Jörgen Bergman, Merja Haaparanta, Olof Solin, Pirkko Sonninen and Juha O. Rinne

    Article first published online : 16 JUL 2001, DOI: 10.1002/mds.1139

  14. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?

    Annals of Neurology

    Volume 41, Issue 1, January 1997, Pages: 58–64, Francois J. G. Vingerhoets, Michael Schulzer, Donald B. Calne and Dr Barry J. Snow

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410410111

  15. Progressive changes of pre- and post-synaptic dopaminergic biomarkers in conscious MPTP-treated cynomolgus monkeys measured by positronemission tomography

    Synapse

    Volume 61, Issue 10, October 2007, Pages: 809–819, Yuji Nagai, Shigeru Obayashi, Kiyoshi Ando, Motoki Inaji, Jun Maeda, Takashi Okauchi, Hiroshi Ito and Tetsuya Suhara

    Article first published online : 27 JUN 2007, DOI: 10.1002/syn.20431

  16. Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study

    Synapse

    Volume 45, Issue 2, August 2002, Pages: 125–133, Y. Ma, V. Dhawan, M. Mentis, T. Chaly, P.G. Spetsieris and D. Eidelberg

    Article first published online : 24 MAY 2002, DOI: 10.1002/syn.10090

  17. Age-specific progression of nigrostriatal dysfunction in Parkinson's disease

    Annals of Neurology

    Volume 69, Issue 5, May 2011, Pages: 803–810, Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L. Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi, Thomas J. Ruth, Chong S. Lee, Donald B. Calne and A. Jon Stoessl

    Article first published online : 18 JAN 2011, DOI: 10.1002/ana.22284

  18. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET

    Synapse

    Volume 48, Issue 3, 1 June 2003, Pages: 109–115, Elina Nurmi, Jörgen Bergman, Olli Eskola, Olof Solin, Tero Vahlberg, Pirkko Sonninen and Juha O. Rinne

    Article first published online : 4 MAR 2003, DOI: 10.1002/syn.10192

  19. Interpreting DTBZ binding data in rodent: Inherent variability and compensation

    Synapse

    Volume 70, Issue 4, April 2016, Pages: 147–152, Miguel Mejias, Jing Yu, Scott Mackey, Katie Dinelle, Vesna Sossi and Doris J. Doudet

    Article first published online : 27 JAN 2016, DOI: 10.1002/syn.21883

  20. Visualizing vesicular dopamine dynamics in Parkinson's disease

    Synapse

    Volume 63, Issue 8, August 2009, Pages: 713–716, Raúl de la Fuente-Fernández, Vesna Sossi, Siobhan McCormick, Michael Schulzer, Thomas J. Ruth and A. Jon Stoessl

    Article first published online : 23 APR 2009, DOI: 10.1002/syn.20653